American Association for Cancer Research

Previous Funding Opportunities for Independent Researchers

Previous opportunities are listed below to offer interested investigators an opportunity to view funding that may be offered again in the future. Details are subject to change.


Previous Funding Opportunities for Independent Researchers

AACR Dharma Master Jiantai Innovative Grant for Lung Cancer Research

Program Summary

The AACR Dharma Master Jiantai Innovative Grant for Lung Cancer Research will provide additional funding to an investigator for an existing project that develops and studies new ideas and approaches that have direct application and relevance to lung cancer.

Following the Grant-in-Aid of Research model, this support supplements existing funding for an investigator conducting a basic or translational research project that will contribute to the acceleration of progress against lung cancer, for the ultimate goal of improving patient care. 

The AACR Dharma Master Jiantai Innovative Grant for Lung Cancer Research is a one-year grant of $10,000 for research expenses, which may include supplemental salary support, equipment, research/laboratory supplies, relevant travel, publication charges for manuscripts that pertain directly to the funded project or other research expenses.

Interested applicants will be asked to submit a proposal of no more than three pages describing the existing lung cancer research project and the proposed use of the Jiantai Innovative Grant Funds. 

Applicant Eligibility Criteria

Applicants must have a medical and/or doctoral degree (including Ph.D., M.D., D.O., D.C., N.D., D.D.S., D.V.M., Sc.D., D.N.S., Pharm.D., or equivalent doctoral degree) in a related field and not currently be a candidate for a further doctoral or professional degree.

At the start of the grant term on July 1, 2014, applicants must:

  • Hold a full-time faculty position with the title of instructor, research assistant professor, assistant professor, or an equivalent full-time faculty position;
  • Have held a full-time faculty position or the equivalent for no more than 10 years (i.e., cannot have had a full-time faculty appointment before July 2, 2004);
  • Work at an academic, medical, or research institution within the United States (There are no citizenship requirements; however, an applicant who is not a U.S. citizen or permanent resident, by submitting an application for this grant, assures that his/her visa status will provide sufficient time to complete the project and grant term within the United States.); and
  • Currently be conducting a basic or translational research project that will contribute to the acceleration of progress against lung cancer.

Employees or subcontractors of a U.S. government entity or for-profit private industry are not eligible.

AACR membership is required. Nonmembers interested in this grant opportunity must submit a satisfactory application for AACR active membership before the paper application deadline. Download an application here.

Research Project Criteria

Only existing basic or translational research projects focusing on the understanding of etiology, diagnosis, treatment, or prevention of lung cancer are eligible to apply for this supplemental funding. This includes existing projects that develop and study new ideas and approaches that have direct application and relevance to lung cancer and that will contribute to the acceleration of progress against lung cancer, for the ultimate goal of improving patient care.

Program Guidelines and Application Instructions

Top of Page

 

Breast Cancer Research Foundation-AACR Grants for Translational Breast Cancer Research

Letter of Intent deadline: October 23, 2013, at noon, Eastern Time
Applicants notified of decision status of Letter of Intent: January 2014
Application deadline (for those invited to apply based on the Letter of Intent): February 5, 2014, at noon, Eastern Time
Decision date: March 2014
Annual Grants Reception and Dinner at the AACR Annual Meeting 2014: April 8, 2014 - Grant recipient must attend the Grants Reception and Dinner and formally accept the grant; complimentary registration will be provided.
Start of grant term: July 1, 2014

Program Summary

The Breast Cancer Research Foundation-AACR Grants for Translational Breast Cancer Research represent a joint effort to promote and support innovative breast cancer research. The research proposed for funding must be translational in nature and must have direct applicability and relevance to breast cancer.

These grants are available to full time, independent junior and senior investigators for breast cancer research projects designed to accelerate the discovery, development, and application of new agents to treat breast cancer and/or for pre-clinical research with direct therapeutic intent. 

The grants provide $181,000 over two years ($90,500 per year) for direct and indirect expenses related to the research project, which may include salary and benefits of the grant recipient and any collaborators, postdoctoral or clinical research fellows, graduate students, and/or research assistants, research/laboratory supplies, equipment, publication charges for manuscripts that pertain directly to the funded project and other research expenses.

It is anticipated that two grants will be funded.

Applicant Eligibility Criteria

Applicants must have a medical and/or doctoral degree (including Ph.D., M.D., D.O., D.C., N.D., D.D.S., D.V.M., Sc.D., D.N.S., Pharm.D., or equivalent doctoral degree) in a related field and not currently be a candidate for a further doctoral or professional degree.

Submissions will be accepted from independent investigators at all levels who are affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world. There are no citizenship or geographic requirements; however, an applicant applying from an institution located within a country where he or she is not a citizen or permanent resident, by submitting a Letter of Intent for this grant, assures that his/her visa status will provide sufficient time to complete the project and grant term at the institution from which they applied.

Employees or subcontractors of a U.S. government entity or for-profit private industry are not eligible.  Employees or subcontractors of a U.S. government entity or for-profit private industry may serve as Collaborators, but no grant funds may be directed towards these individuals.

AACR membership is required. Nonmembers interested in this grant opportunity must submit a satisfactory application for AACR active membership by Friday, October 25, 2013. The application will be applied to 2013 membership dues. An application may be downloaded from the AACR website at www.aacr.org.

Research Project Criteria

Only innovative cancer research projects designed to accelerate the discovery, development, and application of new agents to treat breast cancer and/or for pre-clinical research with direct therapeutic intent will be accepted.

Laboratory-based projects must present plans with clinical collaborators indicating how the work will be translated into the clinic. Similarly, clinical studies must show how the work was derived from basic preclinical work and how results will be channeled back to laboratory-based collaborators.

Program Guidelines and Letter of Intent Instructions

Generously Supported By

Breast Cancer Research Foundation

 

Top of Page

 

Caring for Carcinoid Foundation-AACR Grant for Carcinoid Tumor and Pancreatic Neuroendocrine Tumor Research

Program Summary

The Caring for Carcinoid Foundation-AACR Grant for Carcinoid Tumor and Pancreatic Neuroendocrine Tumor Research represents a joint effort to promote and support innovative cancer research. This grant is available to full time, independent junior and senior investigators to develop and study new ideas and innovative approaches that have direct application and relevance to carcinoid tumors or pancreatic neuroendocrine tumors. Proposed research may be in any discipline of basic, translational, clinical, or epidemiological cancer research.

Applications are invited from researchers currently in the field as well as investigators with experience in other areas of cancer or biomedical research who have promising ideas and approaches that can be applied to carcinoid tumor or pancreatic neuroendocrine tumor research.

The grant provides $250,000 over two years ($125,000 per year) for expenses related to the research project, which may include salary and benefits of the grant recipient and any collaborators (grant recipient/collaborator salaries limited to 25% of the total grant), postdoctoral or clinical research fellows, graduate students, and/or research assistants, research/laboratory supplies, equipment, travel, publication charges for manuscripts that pertain directly to the funded project and other research expenses (indirect costs not permitted).

Applicant Eligibility Criteria

Applicants must have a medical and/or doctoral degree (including Ph.D., M.D., D.O., D.C., N.D., D.D.S., D.V.M., Sc.D., D.N.S., Pharm.D., or equivalent doctoral degree) in a related field and not currently be a candidate for a further doctoral or professional degree.

Applications will be accepted from independent investigators at all levels who are affiliated with an academic, medical or research institution anywhere in the world. There are no citizenship or geographic requirements; however, an applicant applying from an institution located within a country where he or she is not a citizen or permanent resident, by submitting an application for this grant, assures that his/her visa status will provide sufficient time to complete the project and grant term at the institution from which they applied.

Employees or subcontractors of a U.S. government entity or for-profit private industry are not eligible.  Employees or subcontractors of a U.S. government entity or for-profit private industry may serve as Collaborators, but no grant funds may be directed towards these individuals.

AACR membership is required. Nonmembers interested in this grant opportunity must submit a satisfactory application for AACR active membership by Thursday, October 31, 2013. The application will be applied to 2013 membership dues. An application may be downloaded from the AACR website at www.aacr.org.

Research Project Criteria

Proposals will be accepted for new ideas and innovative approaches that have direct application and relevance to carcinoid tumors and pancreatic neuroendocrine tumors. Proposed research projects can be in any discipline including basic, translational, clinical, or epidemiological cancer research.

Applications are invited from researchers currently in the field as well as from investigators with experience in other areas of cancer or biomedical research who have promising ideas or approaches that they will directly apply to carcinoid tumors or pancreatic neuroendocrine tumors. Investigators who have powerful experimental tools that will lead to a better understanding of neuroendocrine tumor biology, elucidate the mechanisms of currently available therapies in neuroendocrine tumors, or identify new treatment targets for carcinoid tumors or pancreatic neuroendocrine tumors are encouraged to apply. However, the applicability of the proposed project to carcinoid tumor or pancreatic neuroendocrine tumor research must be fully described. A track record of research in this specific field is not a requirement for funding.  

The research priorities of the Caring for Carcinoid Foundation include a desire to equitably provide support for both carcinoid tumor and pancreatic neuroendocrine tumor research. Genomic, RNA, and proteomic studies of carcinoid tumors and pancreatic neuroendocrine tumors that complement ongoing genome-wide sequencing efforts funded by Caring for Carcinoid Foundation will be considered, but submission of studies that are duplicative of projects currently funded by the Caring for Carcinoid Foundation should be avoided.

Program Guidelines and Application Instructions

Generously Supported By

Caring for Carcinoid Foundation

 

Top of Page

 

Kure It-AACR Grant for Kidney Cancer Research

Program Summary

The Kure It-AACR Grant for Kidney Cancer Research represents a joint effort to promote and support innovative cancer research. This grant is available to full time, independent junior and senior investigators to develop and study new ideas and innovative approaches that have direct application and relevance to kidney cancer patients. Applicants with experience in other areas of cancer or biomedical/health science research who have promising ideas and approaches that can be applied to kidney cancer research are encouraged to apply.

This grant will support an innovative translational research project designed to improve the survival and quality of life of patients with kidney cancer and lead to individualized therapeutic options for treatment or the development of promising new cancer therapeutics for kidney cancer patients. Emphasis will be placed on proposed projects which will translate into clinical applications within a few year period.

The grant provides $250,000 over two years ($125,000 per year) for direct and indirect expenses related to the research project, which may include salary and benefits of the grant recipient and any collaborators (grant recipient/collaborator salaries limited to 25% of the total grant), postdoctoral or clinical research fellows, graduate students, and/or research assistants, research/laboratory supplies, equipment, travel, publication charges for manuscripts that pertain directly to the funded project and other research expenses.

It is anticipated that one grant will be funded.

Applicant Eligibility Criteria

Applicants must have a medical and/or doctoral degree (including Ph.D., M.D., D.O., D.C., N.D., D.D.S., D.V.M., Sc.D., D.N.S., Pharm.D., or equivalent doctoral degree) in a related field and not currently be a candidate for a further doctoral or professional degree.

Applications will be accepted from independent investigators at all levels who are affiliated with an academic, medical or research institution anywhere in the world. There are no citizenship or geographic requirements; however, an applicant applying from an institution located within a country where he or she is not a citizen or permanent resident, by submitting an application for this grant, assures that his/her visa status will provide sufficient time to complete the project and grant term at the institution from which they applied.

Employees or subcontractors of a U.S. government entity or for-profit private industry are not eligible.  Employees or subcontractors of a U.S. government entity or for-profit private industry may serve as Collaborators, but no grant funds may be directed towards these individuals.

AACR membership is required. Nonmembers interested in this grant opportunity must submit a satisfactory application for AACR active membership by Thursday, November 21, 2013. The application will be applied to 2013 membership dues. An application may be downloaded from the AACR website at www.aacr.org.

All applicants with questions about eligibility should contact AACR at grants@aacr.org before submitting an application.

Research Project Criteria

Proposals will be accepted for new ideas and innovative approaches that have direct application and relevance to kidney cancer patients. Proposed research projects must be translational and designed to improve the survival and quality of life of patients with kidney cancer. Project should aim to lead to individualized therapeutic options for treatment or the development of promising new cancer therapeutics for kidney cancer patients. Emphasis will be placed on proposed projects which will translate into clinical applications within a few year period.

Applications are invited from researchers currently in the field as well as from investigators with experience in other areas of cancer or biomedical/health science research who have promising ideas or approaches that they will directly apply to kidney cancer. Investigators who have powerful experimental tools that will lead to a better understanding of kidney cancer, elucidate the mechanisms of currently available therapies, and/or identify new treatment targets are encouraged to apply. However, the applicability of the proposed project to kidney cancer must be fully described. A track record of research in this specific field is not a requirement for funding.  

Submission of proposals that are duplicative of projects currently funded by Kure It should be avoided.

Program Guidelines and Letter of Intent Instructions

Generously Supported By

Kure It

Top of Page

 

Pancreatic Cancer Action Network-AACR Innovative Grants

Program Summary

The Pancreatic Cancer Action Network-AACR Innovative Grants represent a joint effort to promote and support innovative pancreatic cancer research. They aim to spur creative and cutting-edge ideas and approaches in pancreatic cancer research, including those successful in other areas of cancer that have justifiable promise for pancreatic cancer. The research proposed for funding may be basic, translational, clinical or epidemiological in nature and must have direct applicability and relevance to pancreatic cancer.

These grants are available to full time, independent junior and senior investigators, including those with experience in other areas of cancer or biomedical/health science research who have promising ideas and approaches that can be applied to pancreatic cancer research.

The grants provide $200,000 over two years ($100,000 per year) for direct and indirect expenses related to the research project, which may include salary and benefits of the grant recipient and any collaborators (grant recipient/collaborator salaries limited to 20 percent of the total grant), postdoctoral or clinical research fellows, graduate students and/or research assistants, research/laboratory supplies, equipment and publication charges for manuscripts that pertain directly to the funded project.

Applicant Eligibility Criteria

Applicants must have a medical and/or doctoral degree (including Ph.D., M.D., D.O., D.C., N.D., D.D.S., D.V.M., Sc.D., D.N.S., Pharm.D., or equivalent doctoral degree) in the biomedical sciences or in a field applicable to health science research and not currently be a candidate for a further doctoral or professional degree.

Submissions will be accepted from independent investigators at all levels who are affiliated with an academic, medical or research institution within the United States. There are no citizenship requirements; however, an applicant who is not a U.S. citizen or permanent resident, by submitting an application for this grant, assures that his/her visa status will provide sufficient time to complete the project and grant term within the United States.

Employees or subcontractors of a government entity or for-profit private industry are not eligible. Employees or subcontractors of a government entity or for-profit private industry may serve as collaborators, but no grant funds may be directed towards these individuals.

AACR membership is required. Nonmembers interested in this grant opportunity must submit a satisfactory application for AACR active membership by October 9, 2013. The application will be applied to 2013 membership dues. An application may be downloaded from the AACR website at www.aacr.org.

Research Project Criteria

Proposals will be accepted for new ideas and innovative approaches that have direct application and relevance to pancreatic cancer. New ideas and innovative approaches may include, but are not limited to, those that utilize novel theoretical concepts, approaches or methodologies, instrumentation, or interventions. Such concepts, approaches or methodologies, instrumentation, or interventions may be novel to one field of research or novel in a broad sense, and/or may reflect a significant refinement, improvement, or new application.

Proposals for innovative projects that will develop preliminary data necessary to prepare and submit a competitive research grant application to a major funding agency will be accepted.

Projects may be in any discipline of basic, clinical, translational or epidemiological research, and fall within at least one of the categories of the Common Scientific Outline (Biology; Etiology; Prevention; Early Detection, Diagnosis, and Prognosis; Treatment; or Cancer Control, Survivorship, and Outcomes Research).

Program Guidelines and Letter of Intent Instructions

Generously Supported By

Pancreatic Cancer Action Network

 

Top of Page


Pancreatic Cancer Action Network-AACR Research Acceleration Network Grants

Program Summary

The goal of the Pancreatic Cancer Action Network-AACR Research Acceleration Network (RAN) Grants is to provide funding and strategic assistance to research projects with the potential to double survival for pancreatic cancer by the year 2020. These projects must be implemented by a multi-institutional team and include a clinical component with an endpoint relevant to improving the detection or treatment of pancreatic cancer. The RAN Grants will provide $1,000,000 in funding for direct and indirect expenses related to the research project over a one- to three-year time frame. In addition to the grant, the Pancreatic Cancer Action Network will provide strategic project management support to help optimize project implementation and progress during the grant term.

Applicant Eligibility Criteria

Two co-applicants serving as co-principal investigators (co-PIs) from distinct institutions are required. Additional co-PI’s will be considered but their contribution must be well justified and add a critical perspective or role to the project. Principal investigators (PIs) must have a medical and/or doctoral degree (including Ph.D., M.D., D.O., D.C., N.D., D.D.S., D.V.M., Sc.D., D.N.S., Pharm.D., or equivalent doctoral degree) in the biomedical sciences or in a field applicable to health science research and not currently be a candidate for a further doctoral or professional degree.

The applicant designated as the contact PI must be a full-time independent investigator affiliated with an academic, medical or research institution within the United States. Co-PIs can be affiliated with any academic, medical or research institution in the world.

Past and current recipients of any Pancreatic Cancer Action Network-AACR grant may apply for the RAN Grant if they complied with all progress and financial report requirements. Any individual who currently holds an active AACR grant not funded by the Pancreatic Cancer Action Network may not apply.

There are no citizenship requirements; however, an applicant who is not a U.S. citizen or permanent resident, by submitting an application for this grant, assures that his/her visa status will provide sufficient time to complete the project and grant term within the United States. Additional investigators from the named academic, medical, or research institution(s) are eligible to contribute as co-PIs, project investigators, or collaborators. Employees or subcontractors of a government entity or for-profit private industry cannot be the contact PI (applicant) or a co-PI. Employees or subcontractors of a government entity or for-profit private industry are eligible to be project investigators or collaborators but no grant funds may be directed towards these individuals.

AACR membership is required. Nonmembers interested in this grant opportunity must submit a satisfactory application for AACR active membership by October 9, 2013. The application will be applied to 2013 membership dues. An application may be downloaded from the AACR website at www.aacr.org.

Members of the Scientific Review Committee are not eligible to apply for a Pancreatic Cancer Action Network–AACR Research Acceleration Network Grant.

Research Project Criteria

The basis for the RAN Grant is the recognition that there is basic, translational, clinical, and epidemiological research already underway within the pancreatic cancer community that provides a strong foundation and significant resources that could be brought to bear on the 2020 goal of doubling survival for pancreatic cancer. The RAN Grant is designed to streamline and accelerate progress and effect the desired change in clinical outcome for this disease by linking synergistic capabilities, providing an efficient management structure, and providing funds that can be rapidly and strategically deployed. The project that is selected for a RAN Grant will leverage existing knowledge and experience and be milestone- and timeline-driven. The RAN Grant project must have a clinical component implemented at least by the third year of the funding period. It is recognized that the RAN Grant project is likely to represent a critical step in a longer-term project with a projected completion date of 2020, requiring clinical research beyond the budget and time scope of the RAN Grant. In this case, a plan that outlines the subsequent studies and feasibility of their completion should be provided to allow an assessment of the potential to reach the goal of doubling survival by 2020. Clinical impact, scientific validity, and feasibility are overriding evaluation criteria in selecting the project to be funded by the RAN Grant.

The following scenarios are considered areas where there are sufficient developments within the pancreatic cancer field that could benefit from strategic acceleration. Note these are examples, and applications for the RAN Grant are not restricted to projects that conform to these scenarios.

  • An immunotherapy approach that clinically tests combinations of a previously-tested vaccine with one or several immune modifying factors;
  • Preclinical testing of rational combinations of chemotherapeutic agents currently in early phase clinical development and initial combination clinical trials. A plan is included for subsequent clinical testing of resulting promising combinations if this exceeds the timeframe or budget of the RAN Grant.
  • Neoadjuvant clinical study with tumor tissue for predictive and/or pharmacodynamic marker development;
  • Adaptive clinical trial incorporating multiple targeted agents and predictive biomarkers;
  • Clinical bioavailability studies for a promising imaging agent and the initiation of studies in a high-risk cohort;
  • Large retrospective study with samples from multiple sites for an early detection or predictive serum biomarker panel with a feasible strategic plan for a prospective study. (The prospective study may be outside of the RAN Grant budget or time frame

Proposed RAN Grants must fall within at least one of the categories of the Common Scientific Outline (Biology; Etiology; Prevention; Early Detection, Diagnosis, and Prognosis; Treatment; or Cancer Control, Survivorship, and Outcomes Research).

Program Guidelines and Letter of Intent Instructions

Generously Supported By

Pancreatic Cancer Action Network

 

Top of Page

 

*Adobe Acrobat Reader required

Inquiries

Ashley S. Jones, Staff Assistant

Telephone: 215-446-7280
Fax: 267-825-9601
Email: grants@aacr.org